Evidence map›Paper›PMID 30823889›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development.

Patrizia Sarogni, Orazio Palumbo, Adele Servadio, Simonetta Astigiano, Barbara D'Alessio, Veronica Gatti, Dubravka Cukrov, Silvia Baldari, Maria Michela Pallotta, Paolo Aretini and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Aberrant cohesin function inbioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer.Journal of experimental & clinical cancer research : CR · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cornelia de Lange syndrome and cancer: An open question.American journal of medical genetics. Part A · 2023
    Article
  16. Review
  17. Article
  18. Review
  19. The multifaceted roles of cohesin in cancer.Journal of experimental & clinical cancer research : CR · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 1 country.

Patrizia SarogniInstitute for Genetic and Biomedical Research (IRGB), National Research Council (CNR), Via Moruzzi, 1, 56124, Pisa, Italy.
Orazio PalumboDivision of Medical Genetics, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
Adele ServadioDivision of Pathology, Department of Surgery, University of Pisa, Pisa, Italy.
Simonetta AstigianoIRCCS Ospedale Policlinico San Martino, Department of Translational Oncology, Genoa, Italy.
Barbara D'AlessioInstitute for Genetic and Biomedical Research (IRGB), National Research Council (CNR), Via Moruzzi, 1, 56124, Pisa, Italy.
Veronica GattiIRCCS Regina Elena National Cancer Institute, Department of Research, Advanced Diagnostic and Technological Innovation, Rome, Italy.
Dubravka CukrovInstitute for Genetic and Biomedical Research (IRGB), National Research Council (CNR), Via Moruzzi, 1, 56124, Pisa, Italy.
Silvia BaldariIRCCS Regina Elena National Cancer Institute, Department of Research, Advanced Diagnostic and Technological Innovation, Rome, Italy.
Maria Michela PallottaInstitute for Genetic and Biomedical Research (IRGB), National Research Council (CNR), Via Moruzzi, 1, 56124, Pisa, Italy.
Paolo AretiniFondazione Pisana per la Scienza ONLUS, San Giuliano Terme, Italy.
Felice Dell'OrlettaInstitute for Computational Linguistics (ILC) "A. Zampolli", National Research Council (CNR), Pisa, Italy.
Silvia SodduIRCCS Regina Elena National Cancer Institute, Department of Research, Advanced Diagnostic and Technological Innovation, Rome, Italy.
Massimo CarellaDivision of Medical Genetics, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
Gabriele ToiettaIRCCS Regina Elena National Cancer Institute, Department of Research, Advanced Diagnostic and Technological Innovation, Rome, Italy.
Ottavia BarbieriDepartment of Experimental Medicine, University of Genoa, Genoa, Italy.
Gabriella FontaniniDivision of Pathology, Department of Surgery, University of Pisa, Pisa, Italy.
Antonio MusioInstitute for Genetic and Biomedical Research (IRGB), National Research Council (CNR), Via Moruzzi, 1, 56124, Pisa, Italy. antonio.musio@irgb.cnr.it.
National Research Council · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITCasa Sollievo della Sofferenza · ITUniversity of Pisa · ITInstitute for Computational Linguistics “A. Zampolli” · ITInstitute of Cell Biology and Neurobiology · ITInstitute of Genetic and Biomedical Research · ITInternational Flame Research Foundation · ITOspedale Policlinico San Martino · ITUniversity of Genoa · IT

Funding

Associazione Italiana per la Ricerca sul Cancro IG17374Associazione Italiana per la Ricerca sul Cancro IG18517
6 · The paper itself

Abstract

backgroundCancer cells are characterized by chromosomal instability (CIN) and it is thought that errors in pathways involved in faithful chromosome segregation play a pivotal role in the genesis of CIN. Cohesin forms a large protein ring that binds DNA strands by encircling them. In addition to this central role in chromosome segregation, cohesin is also needed for DNA repair, gene transcription regulation and chromatin architecture. Though mutations in both cohesin and cohesin-regulator genes have been identified in many human cancers, the contribution of cohesin to cancer development is still under debate.

methodsNormal mucosa, early adenoma, and carcinoma samples deriving from 16 subjects affected by colorectal cancer (CRC) were analyzed by OncoScan for scoring both chromosome gains and losses (CNVs) and loss of heterozygosity (LOH). Then the expression of SMC1A was analyzed by immunochemistry in 66 subjects affected by CRC. The effects of SMC1A overexpression and mutated SMC1A were analyzed in vivo using immunocompromised mouse models. Finally, we measured global gene expression profiles in induced-tumors by RNA-seq.

resultsHere we showed that SMC1A cohesin core gene was present as extra-copies, mutated, and overexpressed in human colorectal carcinomas. We then demonstrated that cohesin overexpression led to the development of aggressive cancers in immunocompromised mice through gene expression dysregulation.

conclusionCollectively, these results support a role of defective cohesin in the development of human colorectal cancer.

Indexed as

AdenocarcinomaAdenomaAdultAgedAnimalsCell Cycle ProteinsChromosomal InstabilityChromosomal Proteins, Non-HistoneColorectal NeoplasmsFemaleHeterograftsHumansMaleMiceMice, Inbred NODMice, SCIDCell Cycle ProteinsChromosomal Proteins, Non-HistoneStructural Maintenance of Chromosome Protein 1Chromosome instabilityCohesinGene expression dysregulationHuman colorectal cancer developmentSMC1A

Identifiers

PMID30823889
PMCPMC6397456
OpenAlexW2930373933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.